COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

RESVERATROL and CANCER - New research, 4 papers reviewed and potential use in treating COVID-19 mRNA Vaccine Induced Turbo Cancer (p53, chemo resistance)

William Makis's avatar
William Makis
Apr 25, 2024
∙ Paid

Papers Reviewed:

  • (2020 April, Berretta et al) - Resveratrol in Cancer Patients: From Bench to Bedside

  • (2022, April, Almatroodi) - Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer

  • (2022 Nov, Jang et al) - Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review

  • (2023 Nov, Kursvietiene et al) - Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by William Makis (McGill Medicine) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 William Makis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture